Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Piramal Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
543635
INE0DK501011
52.9497872
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
PPLPHARMA
52.64
33846.35
EPS(TTM)
Face Value(
)
Div & Yield %:
4.85
10
0.04
Date
Headline
06-Dec-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Other General Purpose
11-Nov-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Other General Purpose
08-Nov-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Clarification - Financial Results
30-Oct-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
28-Oct-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
25-Oct-2024
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
24-Oct-2024
Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter
24-Oct-2024
Broader mrkt outperforms; PSU bank shares in demand
24-Oct-2024
Aster DM Healthcare Ltd Surges 9.62%
24-Oct-2024
Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT
1
2
3
4
5
...